Aktienanalyse wird geladen …
STE · NYSE · Medical Devices · USA
208,77 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5,94 Mrd. | 782,3 Mio. | 7,93 $ | 98,7 Mio. | 0,3 Mio · 0,3 % | 0,7 Mio · 0,7 % | 44,3 % | 13,2 % | 9,85 $ | 0,63 $ | 2,46 $ |
| 2024 | 5,46 Mrd. | 614,6 Mio. | 6,20 $ | 99,1 Mio. | 0,3 Mio · 0,3 % | 0,6 Mio · 0,6 % | 44 % | 11,3 % | 7,85 $ | 0,58 $ | 2,23 $ |
| 2023 | 5,14 Mrd. | 378,2 Mio. | 3,81 $ | 99,4 Mio. | 0,3 Mio · 0,3 % | 1,1 Mio · 1,1 % | 43,2 % | 7,4 % | 6,17 $ | 0,57 $ | 2,03 $ |
| 2022 | 4,54 Mrd. | 107,03 Mio. | 1,07 $ | 100,25 Mio. | 0,2 Mio · 0,2 % | — | 43,7 % | 2,4 % | 3,94 $ | 0,39 $ | 1,84 $ |
| 2021 | 4,22 Mrd. | 243,89 Mio. | 2,48 $ | 98,33 Mio. | 0,3 Mio · 0,3 % | — | 44,6 % | 5,8 % | 4,04 $ | 0,59 $ | 1,69 $ |
| 2020 | 3,11 Mrd. | 397,4 Mio. | 4,63 $ | 85,9 Mio. | 0,1 Mio · 0,1 % | — | 43,2 % | 12,8 % | 5,24 $ | 0,30 $ | 1,57 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,49 Mrd. | 200,1 Mio. | 2,04 $ | 97,9 Mio. | 45,8 % | 13,4 % | 2,86 $ |
| Q1 2026 | 1,59 Mrd. | 220,1 Mio. | 2,23 $ | 98,4 Mio. | 43,9 % | 13,9 % | 2,48 $ |
| Q4 2025 | 1,5 Mrd. | 192,9 Mio. | 1,96 $ | 98,6 Mio. | 43,8 % | 12,9 % | 2,02 $ |
| Q3 2025 | 1,46 Mrd. | 191,9 Mio. | 1,94 $ | 98,8 Mio. | 44,2 % | 13,1 % | 2,04 $ |
| Q2 2025 | 1,39 Mrd. | 177,4 Mio. | 1,80 $ | 98,8 Mio. | 45,1 % | 12,8 % | 3,30 $ |
| Q1 2025 | 1,48 Mrd. | 145,7 Mio. | 1,48 $ | 98,76 Mio. | 43,3 % | 9,8 % | 1,92 $ |
| Q4 2024 | 1,37 Mrd. | 173,5 Mio. | 1,75 $ | 98,9 Mio. | 44,5 % | 12,7 % | 2,46 $ |
| Q3 2024 | 1,33 Mrd. | 150 Mio. | 1,51 $ | 99,2 Mio. | 43,6 % | 11,3 % | 1,50 $ |
STERIS Stock: Is STE Underperforming the Healthcare Sector?
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
STERIS (STE) Stock Looks Reasonable On Earnings With Cash Flow Slightly Stretched
STERIS (STE) Could Be 12% Below Fair Value As Conference Focus Returns
STERIS to Present at the Morgan Stanley Healthcare Conference
STERIS Stock Outlook: Is Wall Street Bullish or Bearish?
STERIS plc is a healthcare and life sciences company that provides infection prevention, contamination control, and procedural products and services. The company offers a broad portfolio that includes sterilizers, surgical tables, endoscopy accessories, cleaning chemistries, instrument and scope repair, laboratory testing, and outsourced reprocessing services. Its operations support hospitals, ambulatory surgery centers, pharmaceutical and medical device manufacturers, and research laboratories. STERIS plc also serves biopharmaceutical and life sciences customers with contamination-control equipment, sterilization technologies, and related maintenance services. Through its mix of consumables, capital equipment, and recurring service offerings, the company plays an important role in helping healthcare and production environments maintain sterile conditions and support patient care across global markets.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest STE und jede andere Aktie unbegrenzt.